サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1397354

持続的腎代替療法 (CRRT) の世界市場 (2024～2033年)：モダリティ・製品・地域別の分析・予測・競合情勢

Global Continuous Renal Replacement Therapy Market: Focus on Modality, Product, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033
出版日: | 発行: BIS Research | ページ情報: 英文 149 Pages | 納期: 1～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
持続的腎代替療法 (CRRT) の世界市場 (2024～2033年)：モダリティ・製品・地域別の分析・予測・競合情勢
出版日: 2023年12月17日
発行: BIS Research
ページ情報: 英文 149 Pages
納期: 1～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の持続的腎代替療法 (CRRT) の市場は、急性腎障害 (AKI) の有病率の増加や高度な腎ケアソリューションに対する需要の高まりを背景に、著しい成長を遂げています。

CRRTは、腎機能が低下した患者にとって重要な介入であり、血液浄化のための継続的かつ効率的な方法を提供します。この市場は、血液濾過、血液透析濾過、血液透析など、CRRT処置の効率と有効性を高める革新的な方法の採用によって特徴付けられています。

市場拡大の要因としては、高齢者人口の増加、敗血症や多臓器不全の発生率の上昇、ヘルスケアインフラの進歩なども挙げられます。また、重症患者の管理におけるCRRTの利点に対する医療従事者の意識の高まりも、市場の成長を後押ししています。

当レポートでは、世界の持続的腎代替療法 (CRRT) の市場を調査し、市場の背景・概要、市場成長への各種影響因子の分析、特許動向、法規制環境、市場規模の推移・予測、各種区分/地域別の詳細分析、競合情勢、主要企業の分析などをまとめています。

市場の分類

セグメンテーション1：モダリティ別

  • 持続的静静脈血液濾過 (CVVH)
  • 持続的静静脈血液濾過透析 (CVVHDF)
  • 持続的静静脈血液透析 (CVVHD)
  • 緩徐連続限外濾過 (SCUF)

セグメンテーション2：製品別

  • 持続的腎代替システム
  • ディスポーザブル
  • 透析液および交換液

セグメンテーション3：地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他の地域

目次

エグゼクティブサマリー

第1章 市場

  • 動向：現在および将来の影響評価
  • サプライチェーンの概要
    • バリューチェーン分析
    • マーケットマップ
  • R&Dレビュー
    • 国・企業別の特許出願動向
  • 規制状況
  • 主要な世界的出来事の影響分析：COVID-19
  • 市場力学の概要
    • 市場促進要因
    • 市場抑制要因
    • 市場機会

第2章 用途

  • 用途の分類
  • 用途の概要
  • 世界の持続的腎代替療法 (CRRT) 市場 (モダリティ別)
    • 持続的静静脈血液濾過 (CVVH)
    • 持続的静静脈血液濾過透析 (CVVHDF)
    • 持続的静静脈血液透析 (CVVHD)
    • 緩徐連続限外濾過 (SCUF)

第3章 製品

  • 製品の分類
  • 製品概要
  • 世界の持続的腎代替療法 (CRRT) 市場 (タイプ別)
    • 市場概要
  • 世界の持続的腎代替療法 (CRRT) 市場 (製品別)
    • 持続的腎代替システム
    • ディスポーザブル
    • 透析液および交換液

第4章 地域

  • 地域概要
  • 促進要因・抑制要因
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他の地域

第5章 市場：競合ベンチマーキング・企業プロファイル

  • 次のフロンティア
  • 地域的評価
    • B. Braun SE
    • Baxter
    • Fresenius Medical Care AG
    • Asahi Kasei Corporation
    • NIPRO CORPORATION
    • Toray Medical Co. Ltd.
    • Medtronic plc
    • Medica S.p.A
    • Anjue Medical Equipment Co., Ltd.
    • Ningbo Tinyani Medical Equipment
    • Nikkiso Co., Ltd.
    • SWS Hemodialysis Co., ltd
    • Informed SA
    • Medical Components, Inc.
    • CytoSorbents Corporation

第6章 調査手法

図表

List of Figures

  • Figure 1: Region/country Largest Share of Market
  • Figure 2: Pricing/Cost Analysis by Region, Supply Chain
  • Figure 3: Global Continuous Renal Replacement Therapy Market, by Modality, 2022, 2026, and 2033
  • Figure 4: Global Continuous Renal Replacement Therapy Market, by Age Group, 2022, 2026, and 2033
  • Figure 5: Global Continuous Renal Replacement Therapy Market, by End User, 2022, 2026, and 2033
  • Figure 6: Global Continuous Renal Replacement Therapy Market, by Product, 2022, 2026, and 2033
  • Figure 7: Global Continuous Renal Replacement Therapy Market, Recent Developments
  • Figure 8: Supply chain and Identifying Risks within the Supply Chain
  • Figure 9: Global Continuous Renal Replacement Therapy Market, January 2020-December 2023
  • Figure 10: Global Continuous Renal Replacement Therapy Market, January 2020-December 2023
  • Figure 11: Impact Analysis of Market Navigating Factors
  • Figure 12: Global Continuous Renal Replacement Therapy Market , 2002 and 2022
  • Figure 13: Global Continuous Renal Replacement Therapy Market , 2002 and 2022
  • Figure 14: Global Continuous Renal Replacement Therapy Market , 2002 and 2022
  • Figure 15: U.S. Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 16: U.S. Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 17: Canada Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 18: Canada Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 19: Germany Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 20: Germany Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 21: U.K. Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 22: U.K. Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 23: France Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 24: France Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 25: Italy Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 26: Italy Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 27: Spain Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 28: Spain Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 29: Netherlands Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 30: Netherlands Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 31: Rest of Europe Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 32: Rest of Europe Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 33: China Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 34: China Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 35: Japan Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 36: Japan Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 37: South Korea Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 38: South Korea Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 39: Australia Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 40: Australia Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 41: India Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 42: India Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 43: Rest-of-Asia-Pacific Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 44: Rest-of-Asia-Pacific Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 45: Brazil Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 46: Brazil Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 47: Mexico Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 48: Mexico Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 49: Rest-of-Latin-America Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022, 2026, and 2033
  • Figure 50: Rest-of-Latin-America Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022, 2026, and 2033
  • Figure 51: Strategic Initiatives, 2020 - 2023
  • Figure 52: Share of Strategic Initiatives
  • Figure 53: Data Triangulation
  • Figure 54: Top-Down and Bottom-Up Approach
  • Figure 55: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global Continuous Renal Replacement Therapy Market, Opportunities
  • Table 3: Global Continuous Renal Replacement Therapy Market, by Product, $Million, 2022-2033
  • Table 4: Continuous Renal Replacement Therapy Market, by Region, ($ Million), 2022-2033
  • Table 5: North America Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 6: North America Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 7: U.S. Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 8: U.S. Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 9: Canada Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 10: Canada Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 11: North America Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 12: North America Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 13: Germany Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 14: Germany Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 15: U.K. Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 16: U.K. Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 17: France Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 18: France Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 19: Italy Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 20: Italy Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 21: Spain Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 22: Spain Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 23: Netherlands Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 24: Netherlands Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 25: Rest of Europe Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 26: Rest of Europe Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 27: China Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 28: China Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 29: Japan Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 30: Japan Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 31: South Korea Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 32: South Korea Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 33: Australia Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 34: Australia Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 35: India Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 36: India Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 37: Rest-of-Asia-Pacific Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 38: Rest-of-Asia-Pacific Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 39: Latin America Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 40: Latin America Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 42: Brazil Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 43: Brazil Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 44: Mexico Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 45: Mexico Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 46: Rest-of-Latin-America Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 47: Rest-of-Latin-America Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 48: Rest-of-the-World (RoW) Continuous Renal Replacement Therapy Market, by Modality ($ Million), 2022-2033
  • Table 49: Rest-of-the-World (RoW) Continuous Renal Replacement Therapy Market, by Product ($ Million), 2022-2033
  • Table 51: Market Share
目次
Product Code: BHM1665SA

“Global Continuous Renal Replacement Therapy Market Poised for Remarkable Growth.”

The global continuous renal replacement therapy (CRRT) market is witnessing significant growth, driven by the increasing prevalence of acute kidney injuries (AKI) and the rising demand for advanced renal care solutions. CRRT serves as a vital intervention for patients with impaired kidney function, offering a continuous and efficient method for blood purification. The market is characterized by the adoption of innovative modes, such as hemofiltration, hemodiafiltration, hemodialysis, etc. enhancing the efficiency and efficacy of CRRT procedures.

Factors contributing to the market's expansion include a growing geriatric population, a rise in the incidence of sepsis and multiple organ failure, and advancements in healthcare infrastructure. Additionally, the increasing awareness among healthcare professionals about the benefits of CRRT in managing critically ill patients is bolstering market growth.

Market Segmentation:

Segmentation 1: by Modality

  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Slow Continuous Ultrafiltration (SCUF)

Segmentation 2: by Product

  • Continuous Renal Replacement System
  • Disposables
  • Dialysates and Replacement Fluids

Segmentation 3: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Rest-of-the-World

Key Questions Answered in this Report:

  • What are the focus segments of the global continuous renal replacement therapy market in the upcoming years?
  • What is the value of revenue generated from the continuous renal replacement therapy market across the globe and at what rate is the demand expected to grow in the forecast period?
  • Which product will be the most revenue-generating in the global continuous renal replacement therapy market?
  • Which continuous renal replacement therapy segment is estimated to hold the largest share of the market globally?
  • Which product segment is expected to grow at the highest CAGR during the forecast period?
  • Which modality segment accounted for the largest share of the continuous renal replacement therapy market?
  • What are the key growth factors of this market? What are the major opportunities for existing market players and new entrants in the global continuous renal replacement therapy market? What are the major challenges faced by the existing players in the market?
  • Who are the major players dominating the global continuous renal replacement therapy market space?
  • Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the continuous renal replacement therapy market for the forecast period?
  • What are the key growth factors of this market? What are the major opportunities for existing market players and new entrants in the global continuous renal replacement therapy market? What are the major challenges faced by the existing players in the market?
  • Who are the major players dominating the global continuous renal replacement therapy market space?
  • Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the continuous renal replacement therapy market for the forecast period?

Table of Contents

Executive Summary

1. Markets

  • 1.1. Trends : Current and Future Impact Assessment
    • 1.1.1. Sample Text
    • 1.1.2. Trend 1
    • 1.1.3. Trend 2
    • 1.1.4. Trend 3
  • 1.2. Supply chain Overview
    • 1.2.1. Value Chain Analysis
    • 1.2.2. Market Map
  • 1.3. Research and Development Review
    • 1.3.1. Patent Filing Trend (by Country, Company)
  • 1.4. Regulatory Landscape
  • 1.5. Impact Analysis for Key Global Events- COVID- 19
  • 1.6. Market Dynamics Overview
    • 1.6.1. Market Drivers
    • 1.6.2. Market Restraints
    • 1.6.3. Market Opportunities

2. Application

  • 2.1. Application Segmentation
  • 2.2. Application Summary
  • 2.3. Global Continuous Renal Replacement Therapy Market (by Modality)
    • 2.3.1. Continuous Venovenous Hemofiltration (CVVH)
    • 2.3.2. Continuous Venovenous Hemodiafiltration (CVVHDF)
    • 2.3.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 2.3.4. Slow Continuous Ultrafiltration (SCUF)

3. Products

  • 3.1. Product Segmentation
  • 3.2. Product Summary
  • 3.3. Global Continuous Renal Replacement Therapy Market - (by Type)
    • 3.3.1. Market Overview
      • 3.3.1.1. Analyst View
  • 3.4. Global Continuous Renal Replacement Therapy Market (by Product)
    • 3.4.1. Continuous Renal Replacement System
    • 3.4.2. Disposables
      • 3.4.2.1. Hemofilters
      • 3.4.2.2. Bloodline Sets & Tubes
      • 3.4.2.3. Others
    • 3.4.3. Dialysates and Replacement Fluids

4. Regions

  • 4.1. Regional Summary
  • 4.2. Drivers and Restraints
  • 4.3. North America
    • 4.3.1. Regional Overview
    • 4.3.2. Driving Factors for Market Growth
    • 4.3.3. Factors Challenging the Market
    • 4.3.4. Application
    • 4.3.5. Product
    • 4.3.6. U.S.
    • 4.3.7. U.S. Continuous Renal Replacement Therapy Market by Modality
    • 4.3.8. U.S. Continuous Renal Replacement Therapy Market by Product
    • 4.3.9. Canada
    • 4.3.10. Canada Continuous Renal Replacement Therapy Market by Modality
    • 4.3.11. Canada Continuous Renal Replacement Therapy Market by Product
  • 4.4. Europe
    • 4.4.1. Regional Overview
    • 4.4.2. Driving Factors for Market Growth
    • 4.4.3. Factors Challenging the Market
    • 4.4.4. Application
    • 4.4.5. Product
    • 4.4.6. Germany
    • 4.4.7. Germany Continuous Renal Replacement Therapy Market by Modality
    • 4.4.8. Germany Continuous Renal Replacement Therapy Market by Product
    • 4.4.9. U.K.
    • 4.4.10. U.K. Continuous Renal Replacement Therapy Market by Modality
    • 4.4.11. U.K. Continuous Renal Replacement Therapy Market by Product
    • 4.4.12. France
    • 4.4.13. France Continuous Renal Replacement Therapy Market by Modality
    • 4.4.14. France Continuous Renal Replacement Therapy Market by Product
    • 4.4.15. Italy
    • 4.4.16. Italy Continuous Renal Replacement Therapy Market by Modality
    • 4.4.17. Italy Continuous Renal Replacement Therapy Market by Product
    • 4.4.18. Spain
    • 4.4.19. Spain Continuous Renal Replacement Therapy Market by Modality
    • 4.4.20. Spain Continuous Renal Replacement Therapy Market by Product
    • 4.4.21. Netherlands
    • 4.4.22. Netherlands Continuous Renal Replacement Therapy Market by Modality
    • 4.4.23. Netherlands Continuous Renal Replacement Therapy Market by Product
    • 4.4.24. Rest of Europe
    • 4.4.25. Rest of Europe Continuous Renal Replacement Therapy Market by Modality
    • 4.4.26. Rest of Europe Continuous Renal Replacement Therapy Market by Product
  • 4.5. Asia Pacific
    • 4.5.1. Regional Overview
    • 4.5.2. Driving Factors for Market Growth
    • 4.5.3. Factors Challenging the Market
    • 4.5.4. Application
    • 4.5.5. Product
    • 4.5.6. China
    • 4.5.7. China Continuous Renal Replacement Therapy Market by Modality
    • 4.5.8. China Continuous Renal Replacement Therapy Market by Product
    • 4.5.9. Japan
    • 4.5.10. Japan Continuous Renal Replacement Therapy Market by Modality
    • 4.5.11. Japan Continuous Renal Replacement Therapy Market by Product
    • 4.5.12. South Korea
    • 4.5.13. South Korea Continuous Renal Replacement Therapy Market by Modality
    • 4.5.14. South Korea Continuous Renal Replacement Therapy Market by Product
    • 4.5.15. Australia
    • 4.5.16. Australia Continuous Renal Replacement Therapy Market by Modality
    • 4.5.17. Australia Continuous Renal Replacement Therapy Market by Product
    • 4.5.18. India
    • 4.5.19. India Continuous Renal Replacement Therapy Market by Modality
    • 4.5.20. India Continuous Renal Replacement Therapy Market by Product
    • 4.5.21. Rest-of-Asia-Pacific
    • 4.5.22. Rest-of-Asia-Pacific Continuous Renal Replacement Therapy Market by Modality
    • 4.5.23. Rest-of-Asia-Pacific Continuous Renal Replacement Therapy Market by Product
  • 4.6. Latin America
    • 4.6.1. Regional Overview
    • 4.6.2. Driving Factors for Market Growth
    • 4.6.3. Factors Challenging the Market
    • 4.6.4. Application
    • 4.6.5. Product
    • 4.6.6. Brazil
    • 4.6.7. Brazil Continuous Renal Replacement Therapy Market by Modality
    • 4.6.8. Brazil Continuous Renal Replacement Therapy Market by Product
    • 4.6.9. Mexico
    • 4.6.10. Mexico Continuous Renal Replacement Therapy Market by Modality
    • 4.6.11. Mexico Continuous Renal Replacement Therapy Market by Product
    • 4.6.12. Rest-of-Latin America
    • 4.6.13. Rest-of-Latin-America Continuous Renal Replacement Therapy Market by Modality
    • 4.6.14. Rest-of-Latin-America Continuous Renal Replacement Therapy Market by Product
  • 4.7. Rest-of-the-World (RoW)
    • 4.7.1. Regional Overview
    • 4.7.2. Driving Factors for Market Growth
    • 4.7.3. Factors Challenging the Market
    • 4.7.4. Application
    • 4.7.5. Product

5. Markets - Competitive Benchmarking & Company Profiles

  • 5.1. Next Frontiers…..
  • 5.2. Geographic Assessment
    • 5.2.1. B. Braun SE
      • 5.2.1.1. Overview
      • 5.2.1.2. Top Products / Product Portfolio
      • 5.2.1.3. Top Competitors
      • 5.2.1.4. Target Customers
      • 5.2.1.5. Key Personnel
      • 5.2.1.6. Analyst View
      • 5.2.1.7. Market Share
    • 5.2.2. Baxter
      • 5.2.2.1. Overview
      • 5.2.2.2. Top Products / Product Portfolio
      • 5.2.2.3. Top Competitors
      • 5.2.2.4. Target Customers
      • 5.2.2.5. Key Personnel
      • 5.2.2.6. Analyst View
      • 5.2.2.7. Market Share
    • 5.2.3. Fresenius Medical Care AG
      • 5.2.3.1. Overview
      • 5.2.3.2. Top Products / Product Portfolio
      • 5.2.3.3. Top Competitors
      • 5.2.3.4. Target Customers
      • 5.2.3.5. Key Personnel
      • 5.2.3.6. Analyst View
      • 5.2.3.7. Market Share
    • 5.2.4. Asahi Kasei Corporation
      • 5.2.4.1. Overview
      • 5.2.4.2. Top Products / Product Portfolio
      • 5.2.4.3. Top Competitors
      • 5.2.4.4. Target Customers
      • 5.2.4.5. Key Personnel
      • 5.2.4.6. Analyst View
      • 5.2.4.7. Market Share
    • 5.2.5. NIPRO CORPORATION
      • 5.2.5.1. Overview
      • 5.2.5.2. Top Products / Product Portfolio
      • 5.2.5.3. Top Competitors
      • 5.2.5.4. Target Customers
      • 5.2.5.5. Key Personnel
      • 5.2.5.6. Analyst View
      • 5.2.5.7. Market Share
    • 5.2.6. Toray Medical Co. Ltd.
      • 5.2.6.1. Overview
      • 5.2.6.2. Top Products / Product Portfolio
      • 5.2.6.3. Top Competitors
      • 5.2.6.4. Target Customers
      • 5.2.6.5. Key Personnel
      • 5.2.6.6. Analyst View
      • 5.2.6.7. Market Share
    • 5.2.7. Medtronic plc
      • 5.2.7.1. Overview
      • 5.2.7.2. Top Products / Product Portfolio
      • 5.2.7.3. Top Competitors
      • 5.2.7.4. Target Customers
      • 5.2.7.5. Key Personnel
      • 5.2.7.6. Analyst View
      • 5.2.7.7. Market Share
    • 5.2.8. Medica S.p.A
      • 5.2.8.1. Overview
      • 5.2.8.2. Top Products / Product Portfolio
      • 5.2.8.3. Top Competitors
      • 5.2.8.4. Target Customers
      • 5.2.8.5. Key Personnel
      • 5.2.8.6. Analyst View
      • 5.2.8.7. Market Share
    • 5.2.9. Anjue Medical Equipment Co., Ltd.
      • 5.2.9.1. Overview
      • 5.2.9.2. Top Products / Product Portfolio
      • 5.2.9.3. Top Competitors
      • 5.2.9.4. Target Customers
      • 5.2.9.5. Key Personnel
      • 5.2.9.6. Analyst View
      • 5.2.9.7. Market Share
    • 5.2.10. Ningbo Tinyani Medical Equipment
      • 5.2.10.1. Overview
      • 5.2.10.2. Top Products / Product Portfolio
      • 5.2.10.3. Top Competitors
      • 5.2.10.4. Target Customers
      • 5.2.10.5. Key Personnel
      • 5.2.10.6. Analyst View
      • 5.2.10.7. Market Share
    • 5.2.11. Nikkiso Co., Ltd.
      • 5.2.11.1. Overview
      • 5.2.11.2. Top Products / Product Portfolio
      • 5.2.11.3. Top Competitors
      • 5.2.11.4. Target Customers
      • 5.2.11.5. Key Personnel
      • 5.2.11.6. Analyst View
      • 5.2.11.7. Market Share
    • 5.2.12. SWS Hemodialysis Co., ltd
      • 5.2.12.1. Overview
      • 5.2.12.2. Top Products / Product Portfolio
      • 5.2.12.3. Top Competitors
      • 5.2.12.4. Target Customers
      • 5.2.12.5. Key Personnel
      • 5.2.12.6. Analyst View
      • 5.2.12.7. Market Share
    • 5.2.13. Informed SA
      • 5.2.13.1. Overview
      • 5.2.13.2. Top Products / Product Portfolio
      • 5.2.13.3. Top Competitors
      • 5.2.13.4. Target Customers
      • 5.2.13.5. Key Personnel
      • 5.2.13.6. Analyst View
      • 5.2.13.7. Market Share
    • 5.2.14. Medical Components, Inc.
      • 5.2.14.1. Overview
      • 5.2.14.2. Top Products / Product Portfolio
      • 5.2.14.3. Top Competitors
      • 5.2.14.4. Target Customers
      • 5.2.14.5. Key Personnel
      • 5.2.14.6. Analyst View
      • 5.2.14.7. Market Share
    • 5.2.15. CytoSorbents Corporation
      • 5.2.15.1. Overview
      • 5.2.15.2. Top Products / Product Portfolio
      • 5.2.15.3. Top Competitors
      • 5.2.15.4. Target Customers
      • 5.2.15.5. Key Personnel
      • 5.2.15.6. Analyst View
      • 5.2.15.7. Market Share

6. Research Methodology

  • 6.1. Data Sources
    • 6.1.1. Primary Data Sources
    • 6.1.2. Secondary Data Sources
    • 6.1.3. Data Triangulation
  • 6.2. Market Estimation and Forecast